Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140907
Status:
COMPLETED
Last Update Posted:
2022-02-16
First Post:
2005-08-30
Brief Title:
ALLOGRAFT A Study to Evaluate the Renal Protective Effects of Losartan 0954-222COMPLETED
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Double-Blind Randomized Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate that losartan conventional therapy compared to placebo conventional therapy will reduce the number of RT patients who experience histological lesions of chronic allograft nephropathy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_053 | None | None | None |
| MK0954-222 | None | None | None |